ASH 2022 Conference Coverage
ASH 2022: Venetoclax Combined With Cladribine, Idarubicin, Cytarabine (CLIA) as Induction Therapy in Pts With Newly Diagnosed AML and High-Risk MDS
By
ASH 2022 Conference Coverage
FEATURING
Gautham Borthakur
By
ASH 2022 Conference Coverage
FEATURING
Gautham Borthakur
Login to view comments.
Click here to Login
